Bio Connections Australia explores drug development, early phase clinical trials, translational research and expediting Australia’s great science into commercialization. It […]
Learn more...COSA’s Annual Scientific Meeting
04/11/2020
In 2020 COSA are moving away from their tradition of focussing on one or two cancers, and featuring Quality & […]
Learn more...Study Submission Changes
28/10/2020
Bellberry’s mission is to protect the welfare of research participants and to improve the quality, efficiency and effectiveness of research. […]
Learn more...We are exhibiting at AusBiotech 2020!
21/10/2020
AusBiotech + Invest 2020 – Australia’s largest life science conference is back and will be delivered online live 28 […]
Learn more...Bellberry at AAHMS Annual Scientific Meeting 2020
01/10/2020
The 2020 Australian Academy of Health and Medical Sciences (AAHMS) Annual Scientific Meeting will be held online this year enabling […]
Learn more...ARCS Virtual Summit 2020
30/09/2020
The 2020 ARCS Virtual Summit brings together industry, regulator, academia and researchers to educate, network and unite in a time […]
Learn more...Christmas and New Year 2020-21 Meeting & Submission Dates
18/09/2020
The last meeting of 2020 will be held on Wed 23 December with a submission deadline date of Wed 9 […]
Learn more...HREC Officer Vacancies
15/09/2020
Bellberry Limited is a private, national, independent, not-for-profit organisation, recognised in the McKeon review as a best practice example, supporting […]
Learn more...Batch submissions
01/09/2020
As part of our continuous improvement process, Bellberry has introduced a Batch Processing pathway. This pathway aims to ease the […]
Learn more...CT:IQ: Supporting the Implementation of eConsent in Australia
28/08/2020
CT:IQ is pleased to launch a series of use cases illustrating successful implementation of eConsent in Australia, aimed to be used […]
Learn more...eProtocol Registrations Change
14/08/2020
Bellberry is committed to ensuring the privacy and security for users of our service. In light of recent government announcements […]
Learn more...PRAXIS Webinar: What does the new face of Clinical Trials look like?
28/07/2020
Disruption, adaption and adoption The COVID-19 pandemic has rapidly transformed much of the clinical trials and associated medical device, pharmaceutical, […]
Learn more...COVID-19 FAQ
09/06/2020
COVID-19 FAQ As Bellberry’s position has changed significantly since 2020, please direct your COVID-19 queries to [email protected]. We’re here to […]
Learn more...Progress Reporting Change
02/06/2020
Based on feedback from sites and sponsors, and in our aim for continuous improvement, Bellberry has made further attempts to […]
Learn more...Bellberry receives Australian first recognition
27/05/2020
Bellberry awarded AAHRPP accreditation Bellberry has become the first organisation in Australia to achieve international accreditation for excellence and ethically […]
Learn more...Clinical Trials in the time of COVID-19: A case study
21/05/2020
Perth based not-for-profit clinical trial facility, Linear, got early warning on the seriousness of COVID-19 thanks to a staff member […]
Learn more...Beyond COVID-19: A solution focussed forum
19/05/2020
ACTA, PRAXIS, ARCS and CT:IQ collaborate to host clinical trials online forum launching on International Clinical Trials Day, 20 May 2020 […]
Learn more...Challenges in valuing and paying for combination regimens in oncology
08/05/2020
Report of an international workshop convened by Bellberry, held on November 18-20, in Sydney, Australia In November 2019 Bellberry were […]
Learn more...COVID-19 Update: 1 May 2020
01/05/2020
To assist and guide you through this challenging time, Bellberry will continue to gather, distil and deliver the latest information […]
Learn more...Bellberry CEO joins ARCS COVID-19 Webinar
23/04/2020
Earlier this week Bellberry CEO Kylie Sproston joined Tam Nguyen (St Vincent’s Hospital Melbourne) and James Cokayne (NSW Health) to […]
Learn more...